Contribution: CanExport SMEs
Spartan Bioscience Inc
$75,000.00
Entering European Markets with Spartan’s Medical Platform: rapid CYP2C19 testing and portable COVID19 testing
FY 2020-21 · 2020-07-01
Summary
To commercialize Spartan’s medical platform. We are commercializing the CYP2C19 test upon the success of the European landmark POPular Genetics clinical trial and the COVID19 test to fight the global pandemic.
Department
Program
CanExport SMEs
Recipient
Location
Ottawa|Ottawa, Ontario, Canada
Recipient Type
For-profit organization
Business Number
855952438
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Agreement End Date
2021-02-28
Agreement Number
953830
Agreement Start Date
2020-07-01
Agreement Title
Entering European Markets with Spartan’s Medical Platform: rapid CYP2C19 testing and portable COVID19 testing
Agreement Title (French)
Pénétrer les marchés européens avec la plateforme médicale de Spartan : tests rapides CYP2C19 et tests de dépistage portables de la COVID-19
Agreement Type
Contribution
Agreement Value
$75,000.00
Amendment Number
0
Coverage
CanExport SMEs projects lead to increased export diversification and growth for Canadian small and medium enterprises. | Les projets CanExport PME contribuent à la croissance et à la diversification des exportations des petites et moyennes entreprises canadiennes.
Description
To commercialize Spartan’s medical platform. We are commercializing the CYP2C19 test upon the success of the European landmark POPular Genetics clinical trial and the COVID19 test to fight the global pandemic.
Description (French)
Commercialiser la plate-forme médicale de Spartan. Nous commercialisons le test CYP2C19 à la suite du succès de l'essai clinique européen de référence POPular Genetics et du test de dépistage de la COVID-19 pour lutter contre la pandémie mondiale.
Expected Results
CanExport SMEs is designed to provide direct financial assistance to small- and medium-sized enterprises seeking to develop new export market opportunities and markets, especially in high-growth emerging markets.
Expected Results (French)
CanExport PME a pour objectif de fournir un soutien financier direct aux petites et moyennes entreprises qui cherchent à saisir de nouveaux débouchés à l’exportation, particulièrement dans les marchés émergents à forte croissance.
Federal Riding
Ottawa West--Nepean
Federal Riding (French)
Ottawa-Ouest--Nepean
Federal Riding Number
35079
NAICS Code
334512
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
CanExport SMEs
Program Name (French)
CanExport PME
Program Purpose
CanExport SMEs is designed to provide direct financial assistance to small- and medium-sized enterprises seeking to develop new export market opportunities and markets, especially in high-growth emerging markets.
Program Purpose (French)
CanExport PME a pour objectif de fournir un soutien financier direct aux petites et moyennes entreprises qui cherchent à saisir de nouveaux débouchés à l’exportation, particulièrement dans les marchés émergents à forte croissance.
Recipient Business Number
855952438
Recipient City
Ottawa|Ottawa
Recipient Country
CA
Recipient Legal Name
Spartan Bioscience Inc
Recipient Postal Code
k2h 1b2
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2020-2021-Q2-953830
